Medicine compounds for treating diabetic nephropathy
A technology for diabetic nephropathy and a composition is applied in the field of pharmaceutical compositions for the treatment of diabetic nephropathy, which can solve problems such as unsatisfactory effects and inability to effectively inhibit the development of diabetic nephropathy, and achieve good therapeutic effects, synergistic effects, and complementary mechanisms.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0014] Example 1 tablet
[0015] Prescription Bosentan 50g
[0016] Pioglitazone 10g
[0017] Microcrystalline Cellulose 100g
[0018] 8% hydroxypropyl methylcellulose solution appropriate amount
[0019] Low-substituted hydroxypropyl cellulose 50g
[0020] Magnesium Stearate 2g
[0021] Preparation process: Bosentan and piroglitazone are passed through a 100-mesh sieve, microcrystalline cellulose and low-substituted hydroxypropyl cellulose are passed through a 80-mesh sieve, and the prescribed amount of bosentan, piroglitazone and low-substituted hydroxypropyl cellulose is weighed. Mix the cellulose and microcrystalline cellulose evenly, add an appropriate amount of 8% hydroxypropyl methylcellulose solution to granulate, dry at 60°C, sieve the granules with 16 meshes, add the prescribed amount of magnesium stearate to the dry granules, mix evenly, press Slice and serve.
Embodiment 2
[0022] Example 2 tablet
[0023] Prescription Bosentan 50g
[0024] Rosiglitazone 1.5g
[0025] Microcrystalline Cellulose 100g
[0026] PEG6% solution appropriate amount
[0027] Carboxymethyl Cellulose Calcium 15g
[0028] Magnesium Stearate 2g
[0029] Preparation process: with embodiment 1.
Embodiment 3
[0030] Embodiment 3 Capsules
[0031] Prescription Bosentan 50g
[0032] Pioglitazone 20g
[0033] Pregelatinized starch 50g
[0034] Mannitol 50g
[0035] Lactose 40g
[0036] 6% PVP in 95% ethanol solution
[0037] Micronized silica gel 5g
[0038] Preparation process: pass bosentan, piroglitazone, pregelatinized starch, mannitol, lactose and micropowder silica gel in the prescription through a 100-mesh sieve, mix well, add 6% PVP in 95% ethanol solution to granulate in an appropriate amount, 60 Dry at ℃, sieve through 18 mesh, and then fill the capsules.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com